Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination

Ada, G., Ramsay, A., 1997. Immunopotentiation and the selective induction of immune responses. In: Vaccines, vaccination and the immune response. Raven, Philadelphia. Anonymous, 1980. Council Directive 80/217/EEC of 22 January 1980 introducing community measures for the control of classical swine fever. Anonymous, 1997. Report of the Scientific Veterinary Committee (adopted 17 September 1997): The use of marker vaccines in the control of infectious diseases in particular, classical swine fever. Document VI/8119/97-AL, Commission of the European Communities. Bachmann, 1994, Regulation of IgG antibody titres by the amount persisting of immune-complexed antigen, Eur. J. Immunol., 24, 2567, 10.1002/eji.1830241046 Bouma, 1999, Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus, Vet. Microbiol., 66, 101, 10.1016/S0378-1135(99)00003-6 Bouma, 2000, Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus, Vaccine, 18, 1374, 10.1016/S0264-410X(99)00398-9 Bolin, 1996, Glycoprotein E2 of bovine viral diarrhoea virus expressed in insect cells provides calves limited protection from systemic infection and disease, Arch. Virol., 141, 1463, 10.1007/BF01718248 Bruschke, 1997, A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge, Vaccine, 15, 1940, 10.1016/S0264-410X(97)00125-4 Dahle, 1995, Assessment of safety and protective value of a cell culture modified strain “C” vaccine of hog cholera/classical swine fever virus, Berl. Munch. Tierartzl. Wschr., 108, 20 De Smit, 2000, Prevention of transplacental transmission of moderate-virulent classical swine fever (CSF) virus after a single or double vaccination with a CSF E2 subunit vaccine, Vet. Quart, 22, 150, 10.1080/01652176.2000.9695045 Hoover, 1996, Efficacy of an inactivated feline leukemia virus vaccine, Aids Res. Hum. Retroviruses, 12, 379, 10.1089/aid.1996.12.379 Hulst, 1993, Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera, J. Virol., 67, 5435, 10.1128/JVI.67.9.5435-5442.1993 Ishikawa, 1995, Comparison of the entire nucleotide and deduced amino acid sequences of the attenuated hog cholera vaccine strain GPE- and the wild-type parental strain ALD, Arch. Virol., 140, 1385, 10.1007/BF01322665 Meyers, 1996, Molecular characterisation of pestiviruses, Adv. Virus Res., 47, 53, 10.1016/S0065-3527(08)60734-4 Nauwynck, 1997, Virological protection of sows upon challenge with Aujeszky’s disease virus after multiple vaccinations with attenuated or inactivated vaccines, Zentralbl. Veterinarmed., 44, 609 Ressang, 1967, A comparison between the cellculture, frozen tissue section, impression and mucosal smear techniques for fluorescent antibody in the diagnosis of hog cholera, Tijdschr. Dierg., 92, 567 Reed, 1938, A simple method of estamating fifty percent end points, Am. J. Hyg., 27, 709 Terpstra, C., Dekker A., Barteling, S.J.,Van Maanen, C., 1994. Antibody kinetics and protection of pigs with oil emulsion adjuvated foot-and-mouth disease vaccines. In: Proceedings of the 13th IPVS Congress, Bangkok Thailand, 38. Terptra, 1988, The protective value of vaccine induced neutralizing antibody titres in swine fever, Vet. Microbiol., 16, 123, 10.1016/0378-1135(88)90036-3 Terpstra, 1991, Hog Cholera: an update of present knowledge, Br. Vet. J., 147, 397, 10.1016/0007-1935(91)90081-W Terpstra, 1990, Development and properties of a cell culture produced vaccine for hog cholera based on the Chinese strain, Dtsch. Tierartzl. Wschr., 97, 77 Terpstra, 1984, The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus, Vet. Microbiol., 9, 113, 10.1016/0378-1135(84)90026-9 Terpstra, 1990, Endurance of immunity against foot-and-mouth disease in cattle after three consecutive annual vaccinations, Res. Vet. Sci., 49, 236, 10.1016/S0034-5288(18)31084-1 Usinger, 1997, Comparison of antibody responses to veterinary vaccine antigens potentiated by different adjuvants, Vaccine, 15, 1902, 10.1016/S0264-410X(97)00136-9 Verma, 1998, Haemorrhagic septicaemia vaccines, Vaccine, 16, 1184, 10.1016/S0264-410X(98)80118-7 Wiens, B.L., Bohidar, N.R., Pigeon, J.G., et al., 1996. Duration of protection from clinical hepatitis A disease after vaccination with VAQTA, J. Med. Virol. 49, 235–241. Weiland, E., Ahl, R., Stark, R., Weiland, F., Thiel, H.-J., 1992. A second glycoprotein mediates neutralisation of a pestivirus hog cholera virus, J. Virol. 3677–3682. Wensvoort, 1986, Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosis, Vet. Microbiol., 12, 101, 10.1016/0378-1135(86)90072-6 Wensvoort, 1989, Antigenic differentiation of pestivirus strains with monoclonal antibodies against hog cholera virus, Vet. Microbiol., 21, 9, 10.1016/0378-1135(89)90014-X Wensvoort, G., de Kluijver, E.P., Boonstra, J., Terpstra, C., 1989. Thesis. Production and characterisation of monoclonal antibodies against the “Chinese” strain of hog cholera vaccine virus. State University of Utrecht, Utrecht, The Netherlands. Westergaard, J.M., 1994. Attitude of the European Community to vaccines. In: Wood et al. (Eds.), Vaccines in Agriculture: Immunological Applications to Animal Health and Production. East Melbourne: CSIRO, pp. 13–20.